Register
Login:
Share:
Email Facebook Twitter


Tech company Mporium delivers an outstanding set of Q1 results says CEO De Groot
IronRidge Resources CEO hails spectacular lithium project and money making potential for gold


Motif Bio Share Chat (MTFB)



Share Price: 8.41Bid: 8.32Ask: 8.50Change: 0.00 (0.00%)No Movement on Motif Bio
Spread: 0.18Spread as %: 2.16%Open: 8.70High: 0.00Low: 0.00Yesterday’s Close: 8.41


Share Discussion for Motif Bio


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

ScottPalmer250
Posts: 3
Opinion:No Opinion
Price:8.41
RE: Way forward
Today 13:11
From the fiscal year end:

“To the extent that the Group and Company raise additional funds by issuing equity securities, its existing stockholders may experience significant dilution. Any debt financing, if available, may involve restrictive covenants that impact the Group's and Company's ability to conduct business and achieve its objectives. “
 
Genghis15
Posts: 3,911
Opinion:No Opinion
Price:8.41
RE: Way forward
Today 12:21
There are 342.5m shares in issue, and the last raise was at 6p.

I can think of no reason why a future raise could be done at a higher price, but let's just say they get one away at 8p.

We don't know how much they will try to raise, but we do know "additional funds will be required to resubmit an NDA and reach a new approval date", and there might be a need for further trials also.

@8p per share, £5m would be 63m shares, £10m 125M shares, £20m would be 250m, almost 50% dilution.

I have no idea what the amount will be, and at this stage I guess the co doesn't either, pending the meeting.

I was as sure as anybody here that this was nailed on for approval, and sympathise with the LTHs, some of whom must be badly hit by this. For their sake I hope things will go well.

For myself, I'm comfortable that I took the hit and will not be sweating on it. That might be the wrong call, but I'll live with it..
Hertstrader74
Posts: 1,860
Opinion:No Opinion
Price:8.41
Subtle and not so
Today 12:15
Subtle deramping on here this weekend. Are there some people eating the SP to drop down to buy in?
The.Italian
Posts: 1,091
Premium Chat Member
Opinion:No Opinion
Price:8.41
RE: Way forward
Today 11:27
scott palmer250 i note you use the phrase 'significant dilution" as though it is a quote from the RNS.obviously we can expect some dilution and it may be significant but so far as i can see that phrase has never been used in a formal announcement.if it has please reference it for me as i may have overlooked it.
ScottPalmer250
Posts: 3
Opinion:No Opinion
Price:8.41
RE: Way forward
Today 10:52
Based on hope only as there will be no other logical reason for a rise to those levels given the company won’t say anything of interest until the 3rd June. With ‘significant dilution’ on the cards as per the fiscal end of year RNS why do you think it will be at 15-20p?

No news still on how best to commercialise Iclaprim pending FDA approval, if that were published then agree it would lift the SP as would Directors buys. Both scenarios seem unlikely.

How then will the SP rise?
Hertstrader74
Posts: 1,860
Opinion:No Opinion
Price:8.41
Way forward
Today 10:47
Yes we are all waiting on the minutes in June and then we can gauge where the large placing may be. I strongly suspect the share price will be at a much higher level than currently. I would be dissapointed if the price has not recovered to 15-20 by then.
Genghis15
Posts: 3,911
Opinion:No Opinion
Price:8.41
RE: Ft
Today 09:00
gents, I refer you to my last sentence.

My previous posts make clear I am relaxed either way ; if the SP falls as a result of the placing we know must come, I may buy back in.

If it does not, either bcos of a higher placing price or an opportunistic TO, I will miss out. What I post (or not) on here will not make one iota of difference to those outcomes, nor to the SP.
Thaiflyer1
Posts: 38
Opinion:No Opinion
Price:8.41
RE: Ft
Today 08:39
What i said was " I took my money out at 8p. ......... and my decision mb wrong

If you took your money out at 8p, why are you still hanging about?.......just pay the 9p and get back in.......no need to deramp
ScottPalmer250
Posts: 3
Opinion:No Opinion
Price:8.41
Overview of Motif
Today 08:37
Been watching this board for awhile and have decided that we all need to decide how best to approach the AGM so have joined.

Since the disaster in Feb I have wondered how bad it is. The CRL genuinely seemed to come out of the blue for the BOD, unless they are utter charlatans. For now I give them the benefit of the doubt.

I took some comfort in the willingness to do the webcast. The reaction to the precarious financial situation was as good as could be despite the fact that a plan B should have been in place. I also am encouraged that the main institutional investors have remained albeit with reduced stakes since the Feb 14th SP masscare. Maybe it’s just to recoup some loses on a miracle but I genuinely feel Sandgrove not selling a share is of small comfort to investors.

Reading the final year statements. They seem to feel the CRL issues are addressable. How long and how expensive no one knows. They threat of significant dilution for existing shareholders is written in black and white. The reasons to stay with this investment could vanish depending on that fund raise.

I was encouraged by the data at the recent Amsterdam conference but the SP again reacted poorly to another conference. That is a concern. It has never risen on the back of a conference why?

I am concerned that the AGM is before the 3rd June. I think it smacks of cowardice to not face investors after the official minutes. The dilution could be significant and I am afraid they don’t want to face the music face to face. They can hide at the AGM behind the ‘we can’t say anything’ line due to not being in possession of the official minutes. The CEO is hugely unimpressive and this tally’s with his personality. We are stuck with him so:

Questions for the AGM:

Why didn’t the European submission go in as promised? Why did it get pulled without explanation?

Why were the HABP trials dropped from the companies presentations without explanation? Were the difficulties with the liver toxicity known already so that’s why the ability to go to raise funds was impossible?

Will they need to pay a fee for the resubmitted NDA? How long do they think a new PDUFA date will take to finalise?

Given the recent bankruptcy at Achoagen what is different for Motif and Iclaprim in their opinion that won’t deliver disappointing sales and a failure to penetrate the Vancomycin domination?

Why haven’t they frozen salaries or at the very least used their salaries to buy into Motif at these bargain basement prices to show support give they were happy to bang the drum when Brokers were advertising £1+ on approval?

How far down the line are they with a commercial partner and if far, why can’t they announce it peddling approval from the FDA?

Any other questions people can think of would be good for someone to pool them for the 22nd May to get a coherent line of questions for the BOD to answer. I am Croatia on business so can’t attend but would thank anyone who is going to be as ruthl
calamari
Posts: 516
Opinion:No Opinion
Price:8.41
RE: Ft
Today 05:48
Don't read it, just deramping.
Genghis15
Posts: 3,911
Opinion:No Opinion
Price:8.41
RE: Ft
Sun 18:35
I used a gift link which should have enabled others to read it, so sorry if that didn't work.

Birdseye, I thought it relevant ; didn't know it had been posted b4. I never said "sold at 8p and will buy in when it’s lower ?", so stop trying to be a smartarse.

What i said was " I took my money out at 8p. ......... and my decision mb wrong."

Small minded sniping only diminishes the poster, not the target.
Hertstrader74
Posts: 1,860
Opinion:No Opinion
Price:8.41
Ft
Sun 17:27
It’s an article on Achaogen who went bust last week, it was mentioned on these boards last week. Remember they had over 100 staff. MTFB only has 8 full time and (well paid) staff, with dissapointing sales of there UTI anti biotic
Birdseye
Posts: 1,790
Premium Chat Member
Opinion:No Opinion
Price:8.41
RE: Ft
Sun 17:24
Can’t read it, I’m afraid.

Is it a report of you telling us you sold at 8p and will buy in when it’s lower ? Because, if it is, we have already read it.
Citytilidie
Posts: 1,766
Premium Chat Member
Opinion:No Opinion
Price:8.41
RE: Ft
Sun 17:19
Would be okay if I subscribed to FT ?
Genghis15
Posts: 3,911
Opinion:No Opinion
Price:8.41
Ft
Sun 15:29
Not an encouraging story, I'm afraid.

https://on.ft.com/2KTb2Ia
marineville
Posts: 10,271
Opinion:No Opinion
Price:8.41
RE: remind thoth next trashtalk of MTFB
Sat 22:43
not that much effort. if you know how... took all of 5 mins and happy to undermine his trolling here...
Birdseye
Posts: 1,790
Premium Chat Member
Opinion:No Opinion
Price:8.41
RE: remind thoth next trashtalk of MTFB
Sat 21:56
I would suggest you put in way to effort for that turd but that is some damning quotes from Charlie Big Bananas aka pish throth2
marineville
Posts: 10,271
Opinion:No Opinion
Price:8.41
remind thoth next trashtalk of MTFB
Sat 21:50
in all that time thoth2 has been its head cheerleader and vuvuzela blower... he has pulled in so many investors into SAR with his informed opinions - he IS informed but he's not clairvoyant about sp of anything much,,, next the deramps MTFB remind him of his own rampity position on SAR:

from april 2018:

May 9th srra next form10k which may have a provisiin for our bext milestone. Failing that aug9th. Guesstimate c 6m to us. Should see us 3p. Tyk2 licence in the next 6 months should give an additional 10 to 20p. I will then be investing half of profits in srra depending on prices. But looking for some blow off action here first.

wrong on (they placed £850mill @ 0.65), wrong on 3p in 2018, wrong on 10-20p in 2018.

current SAR sp is 0.8... so, only 25% of his lowest estimate on the sp for 2018...and 96% wrong on the best price he predicted.

next time he trash talks your investment, feel free to cut'n'paste some of these numbers... :)
marineville
Posts: 10,271
Opinion:No Opinion
Price:8.41
whatever the price is pre 3june...
Sat 21:21
the temptation to sell will be strong, unless it hasn't moved higher than 12p...

most holders who were holding at 40p aren't going to be inclined to even trade this at 70% down... might as well just hold on and hope for better news out of the meeting and a well defined timeline for resubmission...
waccybaccy
Posts: 160
Opinion:No Opinion
Price:8.41
RE: Clinical trials data
Sat 19:58
If it gets to 20p pre-June 3rd the temptation to sell will be epic.
MrNation
Posts: 261
Opinion:No Opinion
Price:8.41
RE: Top up
Sat 18:52
Been topping up on dips, if ducks line up we will all get a kings ransom
Hertstrader74
Posts: 1,860
Opinion:No Opinion
Price:8.41
Clinical trials data
Sat 12:14
Just been reading back through Revive 1 and 2 results. No mention whatsoever about liver concerns. From Revive 1 “No significant differences were seen between treatment groups in mean values or mean changes in other routine serum laboratory parameters, urinalysis results, vital signs or physical examinations during treatment.” So, that to me means, no significant changes in LFTs(liver function tests), nor physical examination of the patient, so no liver pathology/toxicity.
This does really me make me wonder if this is just a massive cock-up by the company in not providing the sufficient data on LFTs during the trial( which they should now easily be able to provide to the FDA as these were clearly obtained during the trial). Or possibly there has been very minor rises in liver enzymes that are not clinically significant and they are trying to get a “clean label” and not have this in the drug information pack, when in reality many drugs can not be used or should be used “with caution” in probably older patients over 65s with liver disease, so this is not a barrier to the licensing of a drug.
If this has been the case this will gradually( or not so gradually!) re-gain the losses in SP, so might not get back to 40p before next FDA decision but could easily get up to 20-25p as June 3rd approaches
Kettle
Posts: 160
Opinion:No Opinion
Price:8.41
RE: Top up
Sat 10:43
Have a look at Sprout pharma and their Fda failure, it makes me think how motif are acting so well.
Kettle
Posts: 160
Opinion:No Opinion
Price:8.41
RE: Top up
Sat 10:26
Rubbish advice. Looked behind my sofa and all I found was the dog ! Bet Thoth could make something out of that.
Hertstrader74
Posts: 1,860
Opinion:No Opinion
Price:8.41
Top up
Sat 07:45
Found a few quid behind the sofa so will be topping up on Tuesday. Happy easter




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.